Circular Genomics: Funding, Investors & Team (Sep 2026)
Circular Genomics, headquartered in Albuquerque, New Mexico, is a biotech and genomics firm that focuses on creating RNA-based assays for diagnosing and treating psychiatric and neurological disorders. Established in 2021, this company specializes in the development of innovative solutions in these fields.
Circular Genomics has raised $27.8M across 3 funding rounds on record, the most recent a Series A of $15.0M announced in Dec 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Circular Genomics Company Profile and Key Stats
Latest funding round on record: Dec 2025.
Circular Genomics Funding Rounds
Circular Genomics raised $4.5M in a Seed announced in Dec 2021.
2.1 years later, a Series A of $8.3M was announced in Jan 2024.
1.9 years later, a Series A of $15.0M was announced in Dec 2025.
Circular Genomics Founders and Leadership Team
Contact details for the Circular Genomics team: 1 of 2 have an email address on file.
Start 14-day free trial →Circular Genomics Funding Compared to Other Biotechnology Startups
Circular Genomics' latest round of $15.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Circular Genomics in Biotechnology and Albuquerque
Companies Similar to Circular Genomics
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Circular Genomics Funding FAQs
What does Circular Genomics do?
Circular Genomics, headquartered in Albuquerque, New Mexico, is a biotech and genomics firm that focuses on creating RNA-based assays for diagnosing and treating psychiatric and neurological disorders. Established in 2021, this company specializes in the development of innovative solutions in these fields.
How much funding has Circular Genomics raised?
Circular Genomics has raised $27.8M across 3 rounds on record. The most recent is a Series A of $15.0M announced in Dec 2025.
When did Circular Genomics last raise funding?
Circular Genomics' most recent funding round on record is a Series A of $15.0M, announced in Dec 2025.
Who founded Circular Genomics?
FundedIQ lists Alexander Hafez (Founder), Nikolaos Mellios (Founder) at Circular Genomics.
Where is Circular Genomics headquartered?
Circular Genomics is based in Albuquerque, New Mexico, United States.
How many employees does Circular Genomics have?
Circular Genomics is in the 1-10 employee band.
How does Circular Genomics' funding compare to other Biotechnology startups?
Circular Genomics' latest round of $15.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Circular Genomics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Circular Genomics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.